Back
Cronos Group 10K Form
Sell
18
CRON
Cronos Group
Last Price:
$1.75
Seasonality Move:
-6.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-02-26 | 10K | CRON/Cronos Group Annual |
2020-11-05 | 10Q | CRON/Cronos Group Quarterly |
2020-08-06 | 10Q | CRON/Cronos Group Quarterly |
2020-05-08 | 10Q | CRON/Cronos Group Quarterly |
2020-03-30 | 10K | CRON/Cronos Group Annual |
2020-03-02 | 10K | CRON/Cronos Group Annual |
Receive CRON News And Ratings
See the #1 stock for the next 7 days that we like better than CRON
CRON Financial Statistics
Sales & Book Value
Annual Sales: | $117.6M |
---|---|
Cash Flow: | $4M |
Price / Cash Flow: | 117.81 |
Annual Sales: | $2.78 |
Price / Book: | 0.63 |
Profitability
EPS (TTM): | 0.11000 |
---|---|
Net Income (TTM): | $41.1M |
Gross Margin: | $25.2M |
Return on Equity: | 3.76% |
Return on Assets: | 3.61% |
Cronos Group Earnings Forecast
Key Cronos Group Financial Ratios
-
The Gross Profit Margin over the past 11 years for CRON is 21.42%.
-
The Selling, General & Administrative Expenses for CRON have been equal to 65.31% of Gross Profit Margin.
-
The Research & Development expenses have been 3.60% of Revenue.
-
The Net Earning history of CRON is 34.93% of Total Revenues.
-
Per Share Earnings over the last 11 years have been positive in 6 years.
Cronos Group Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | CRON |
CUSIP: | 22717L |
Website: | thecronosgroup.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 18.84 |
Quick Ratio: | 17.88 |
Price-to-Earnings
Trailing P/E Ratio: | 15.91 |
---|---|
Forward P/E Ratio: | 0 |
CRON Technical Analysis vs Fundamental Analysis
Sell
18
Cronos Group (CRON)
is a Sell
Is Cronos Group a Buy or a Sell?
-
Cronos Group stock is rated a SellThe current Cronos Group [CRON] share price is $1.75. The Score for CRON is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.